Literature DB >> 15350966

Inflammation alters cation chloride cotransporter expression in sensory neurons.

Begonia M Morales-Aza1, Naomi L Chillingworth, John A Payne, Lucy F Donaldson.   

Abstract

Cation chloride cotransporters have been proposed to play a role in the modulation of neuronal responses to gamma-aminobutyric acid (GABA). In conditions of neuronal damage, where neuronal excitability is increased, the expression of the KCC2 transporter is decreased. This is also seen in spinal cord in models of neuropathic pain. We have investigated the expression of the Na-K-Cl, and K-Cl cotransporters NKCC1 and KCC2, in dorsal root ganglion (DRG) and spinal sensory neurons during arthritis, a condition in which neuronal excitability is also increased. NKCC1 was expressed in control DRG neurons, and its expression was decreased in arthritis. Both NKCC1 and KCC2 were expressed in sensory neurons in the spinal cord. In acute arthritis, both NKCC1 and KCC2 mRNA increased in superficial but not deep dorsal horn, and this was accompanied by an increase in protein expression. In chronic arthritis, NKCC1 expression remained raised, but KCC2 mRNA and protein expression returned to control levels. Altered KCC2 and NKCC1 expression in arthritis may contribute to the control of spinal cord excitability and may represent novel therapeutic targets in the treatment of inflammatory pain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15350966     DOI: 10.1016/j.nbd.2004.05.010

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  27 in total

1.  Molecular and functional expression of cation-chloride cotransporters in dorsal root ganglion neurons during postnatal maturation.

Authors:  Shihong Mao; Tomás Garzon-Muvdi; Mauricio Di Fulvio; Yanfang Chen; Eric Delpire; Francisco J Alvarez; Francisco J Alvarez-Leefmans
Journal:  J Neurophysiol       Date:  2012-03-28       Impact factor: 2.714

Review 2.  Role of cation-chloride-cotransporters (CCC) in pain and hyperalgesia.

Authors:  Theodore J Price; Fernando Cervero; Yves de Koninck
Journal:  Curr Top Med Chem       Date:  2005       Impact factor: 3.295

3.  Modulation of spinal GABAergic analgesia by inhibition of chloride extrusion capacity in mice.

Authors:  Marina N Asiedu; Galo Mejia; Michael K Ossipov; T Phillip Malan; Kai Kaila; Theodore J Price
Journal:  J Pain       Date:  2012-04-25       Impact factor: 5.820

4.  NKCC1 cotransporter inactivation underlies embryonic development of chloride-mediated inhibition in mouse spinal motoneuron.

Authors:  Alain Delpy; Anne-Emilie Allain; Pierre Meyrand; Pascal Branchereau
Journal:  J Physiol       Date:  2007-12-20       Impact factor: 5.182

5.  Novel repression of Kcc2 transcription by REST-RE-1 controls developmental switch in neuronal chloride.

Authors:  Michele Yeo; Ken Berglund; George Augustine; Wolfgang Liedtke
Journal:  J Neurosci       Date:  2009-11-18       Impact factor: 6.167

6.  Calmodulin contributes to gating control in olfactory calcium-activated chloride channels.

Authors:  Hiroshi Kaneko; Frank Möhrlen; Stephan Frings
Journal:  J Gen Physiol       Date:  2006-06       Impact factor: 4.086

7.  Spinal cord mechanisms mediating behavioral hyperalgesia induced by neurokinin-1 tachykinin receptor activation in the rostral ventromedial medulla.

Authors:  S C Lagraize; W Guo; K Yang; F Wei; K Ren; R Dubner
Journal:  Neuroscience       Date:  2010-10-01       Impact factor: 3.590

8.  Behavioral analysis of Ste20 kinase SPAK knockout mice.

Authors:  Yang Geng; Nellie Byun; Eric Delpire
Journal:  Behav Brain Res       Date:  2009-12-16       Impact factor: 3.332

9.  The RCC1 domain of protein associated with Myc (PAM) interacts with and regulates KCC2.

Authors:  Nicole Garbarini; Eric Delpire
Journal:  Cell Physiol Biochem       Date:  2008-07-25

10.  Inflammation-induced shift in the valence of spinal GABA-A receptor-mediated modulation of nociception in the adult rat.

Authors:  Vanessa C Z Anseloni; Michael S Gold
Journal:  J Pain       Date:  2008-05-07       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.